Miguel Deltoro-Garcia
Valencia, VC, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Hidden dengue burden in migrant visiting friends and relatives travellers: A seroprevalence study in a tertiary Infectious Diseases clinic in Spain.
Journal: Enfermedades infecciosas y microbiologia clinica (English ed.)
Published: March 09, 2026
Physician Knowledge of Chagas Disease in a Non-Endemic Country: A Nationwide Cross-Sectional Survey.
Physician Knowledge of Chagas Disease in a Non-Endemic Country: A Nationwide Cross-Sectional Survey.
Journal: Tropical medicine & international health : TM & IH
Published: December 03, 2025
Effectiveness and Safety of Bictegravir/Emtricitabine/Tenofovir Alafenamide in People with HIV: A Real-World Data from the Spanish BICSTaR Cohort.
Journal: HIV/AIDS (Auckland, N.Z.)
Published: May 09, 2025
Letter: Impact of Nonalcoholic Fatty Liver Disease on the Survival of People Living With HIV-Authors' Reply.
Journal: Alimentary pharmacology & therapeutics
Published: February 24, 2025
Value of public health interventions for HIV, HBV and HCV integrated screening: The FOCUS-CRIVALVIR programme.
Journal: Annals of epidemiology
Published: January 10, 2025
Thigh Injections of Cabotegravir + Rilpivirine in Virally Suppressed Adults With HIV-1: A Substudy of the Phase 3b ATLAS-2M Study.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: August 14, 2024
HIV-1 resistance and virological failure to treatment with the integrase inhibitors bictegravir, cabotegravir, and dolutegravir: a systematic literature review.
Journal: AIDS reviews
Published: August 12, 2024
Current prevalence of hepatitis delta diagnosis in Valencia, Spain.
Journal: Scientific reports
Published: August 03, 2024
Current characteristics of patients with hepatitis C virus: results from an automated alert system.
Journal: Revista espanola de enfermedades digestivas
Published: March 19, 2024
Opportunistic population screening as a hepatitis elimination strategy: the CRIVALVIR-FOCUS program.
Opportunistic population screening as a hepatitis elimination strategy: the CRIVALVIR-FOCUS program.
Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: February 07, 2024
Reassessing HIV Detection Strategies: An Analysis of Opportunistic Screening vs. Indicator-Condition-Driven Diagnosis in Valencia, Spain.
Journal: Journal of community health
Published: January 23, 2024
Corrigendum for HIV-1 resistance and virological failure to treatment with the integrase inhibitors bictegravir, cabotegravir, and dolutegravir: a systematic literature review.
Journal: AIDS reviews
Published: January 01, 2024
Last Updated: 09/26/2026